Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5145)
All Articles published online
|
Feb 21, 2011 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang ZL, Zheng Q, Yan J, Pan Y, Wang ZG. Upregulated CD133 expression in tumorigenesis of colon cancer cells. World J Gastroenterol 2011; 17(7): 932-937 [PMID: 21412503 DOI: 10.3748/wjg.v17.i7.932] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i7/932.htm |
| Number | Citing Articles |
| 1 |
Cho-Won Kim, Hong Kyu Lee, Min-Woo Nam, Gabsang Lee, Kyung-Chul Choi. The role of KiSS1 gene on the growth and migration of prostate cancer and the underlying molecular mechanisms. Life Sciences 2022; 310: 121009 doi: 10.1016/j.lfs.2022.121009
|
| 2 |
Bing-jie Liu, Qi-ying Xu, Wei-dong Yu, Na Li, Tian Yao, Li-jun Zhao, Jian-liu Wang, Li-hui Wei, Xiao-ping Li. Study of the Characterization of Side Population Cells in Endometrial Cancer Cell Lines: Chemoresistance, Progestin Resistance, and Radioresistance. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00070
|
| 3 |
Ming Hua Ge, Xu Hang Zhu, Yi Ming Shao, Chao Wang, Ping Huang, Yun Wang, Yu Jiang, Yasen Maimaitiyiming, En Chen, Chang Yang, Hua Naranmandura. Synthesis and characterization of CD133 targeted aptamer–drug conjugates for precision therapy of anaplastic thyroid cancer. Biomaterials Science 2021; 9(4): 1313 doi: 10.1039/D0BM01832E
|
| 4 |
Yuchen Jin, Beibei Liu, Muhsin H. Younis, Gang Huang, Jianjun Liu, Weibo Cai, Weijun Wei. Next-Generation Molecular Imaging of Thyroid Cancer. Cancers 2021; 13(13): 3188 doi: 10.3390/cancers13133188
|
| 5 |
John Lynes, Victoria Sanchez, Gifty Dominah, Anthony Nwankwo, Edjah Nduom. Current Options and Future Directions in Immune Therapy for Glioblastoma. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00578
|
| 6 |
Jie Chen, Lin Lin, Zhaopei Guo, Caina Xu, Huayu Tian, Kinam Park, Xuesi Chen. Synergistic treatment of cancer stem cells by combinations of antioncogenes and doxorubicin. Journal of Drug Delivery Science and Technology 2015; 30: 417 doi: 10.1016/j.jddst.2015.06.004
|
| 7 |
Zhaoting Yang, Chengye Zhang, Wenbo Qi, Yan Cui, Yanhua Xuan. GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma. Experimental Cell Research 2018; 373(1-2): 145 doi: 10.1016/j.yexcr.2018.10.006
|
| 8 |
Xia Chen, Hua Guan, Xiao‑Dan Liu, Da‑Fei Xie, Yu Wang, Teng Ma, Bo Huang, Ping‑Kun Zhou. p53 positively regulates the expression of cancer stem cell marker CD133 in HCT116 colon cancer cells. Oncology Letters 2018; doi: 10.3892/ol.2018.8619
|
| 9 |
Carole Mélin, Aurélie Perraud, Hussein Akil, Marie-Odile Jauberteau, Philippe Cardot, Muriel Mathonnet, Serge Battu. Cancer Stem Cell Sorting from Colorectal Cancer Cell Lines by Sedimentation Field Flow Fractionation. Analytical Chemistry 2012; 84(3): 1549 doi: 10.1021/ac202797z
|
| 10 |
Nuoya Wang, Liqing Chen, Wei Huang, Zhonggao Gao, Mingji Jin. Current Advances of Nanomaterial-Based Oral Drug Delivery for Colorectal Cancer Treatment. Nanomaterials 2024; 14(7): 557 doi: 10.3390/nano14070557
|
| 11 |
Zongyi Wei, Yuxin Zhou, Rongjie Wang, Jin Wang, Zhenhua Chen. Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy. Pharmaceutics 2022; 14(12): 2561 doi: 10.3390/pharmaceutics14122561
|
| 12 |
Chih-Sin Hsu, Chien-Yi Tung, Chih-Yung Yang, Chi-Hung Lin, Wael El-Rifai. Response to Stress in Early Tumor Colonization Modulates Switching of CD133-Positive and CD133-Negative Subpopulations in a Human Metastatic Colon Cancer Cell Line, SW620. PLoS ONE 2013; 8(4): e61133 doi: 10.1371/journal.pone.0061133
|
| 13 |
Chonggao Wang, Yewei Zhang. Current Application of Nanoparticle Drug Delivery Systems to the Treatment of Anaplastic Thyroid Carcinomas. International Journal of Nanomedicine 2023; : 6037 doi: 10.2147/IJN.S429629
|
| 14 |
J. Chen, Jianyong Zhao, J. Ding, Ziwei Wang, Jiyi Du, Chenchang Wu. Knocking down LSD1 inhibits the stemness features of colorectal cancer stem cells. Brazilian Journal of Medical and Biological Research 2020; 53(7) doi: 10.1590/1414-431x20209230
|
| 15 |
Galina Botchkina. Colon cancer stem cells – From basic to clinical application. Cancer Letters 2013; 338(1): 127 doi: 10.1016/j.canlet.2012.04.006
|
| 16 |
Rebecca Sanders, Deborah J. Mason, Carole A. Foy, Jim F. Huggett. Considerations for accurate gene expression measurement by reverse transcription quantitative PCR when analysing clinical samples. Analytical and Bioanalytical Chemistry 2014; 406(26): 6471 doi: 10.1007/s00216-014-7857-x
|
| 17 |
Carole Mélin, Aurélie Perraud, Christophe Bounaix Morand du Puch, Elodie Loum, Stéphanie Giraud, Philippe Cardot, Marie-Odile Jauberteau, Christophe Lautrette, Serge Battu, Muriel Mathonnet. Sedimentation field flow fractionation monitoring of in vitro enrichment in cancer stem cells by specific serum-free culture medium. Journal of Chromatography B 2014; 963: 40 doi: 10.1016/j.jchromb.2014.05.039
|
| 18 |
Sònia Palomeras, Santiago Ruiz-Martínez, Teresa Puig. Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance. Molecules 2018; 23(9): 2193 doi: 10.3390/molecules23092193
|
| 19 |
Tong-tong Zhang, Hai-peng Chen, Su-yang Yu, Shi-peng Zhao. LncRNA HOXC-AS3 overexpression inhibits TGF-β2-induced colorectal cancer cell migration and invasion by sponging miR-1269. Human & Experimental Toxicology 2022; 41: 096032712210936 doi: 10.1177/09603271221093630
|
| 20 |
Jaime Antonio Oliver, Raúl Ortiz, Consolación Melguizo, Pablo Juan Álvarez, Jaime Gómez-Millán, Jose Prados. Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-511
|
| 21 |
Ying Feng, Zhaoting Yang, Chengye Zhang, Nan Che, Xingzhe Liu, Yanhua Xuan. B7-H4 induces epithelial–mesenchymal transition and promotes colorectal cancer stemness. Pathology - Research and Practice 2021; 218: 153323 doi: 10.1016/j.prp.2020.153323
|
| 22 |
M Ozawa, Y Ichikawa, Y-W Zheng, T Oshima, H Miyata, K Nakazawa, H-B Guan, M Shiozawa, M Akaike, K Watanabe, M Ota, S Fujii, C Kunisaki, T Ishikawa, K Tanaka, H Akiyama, I Endo, H Taniguchi. Prognostic significance of CD44 variant 2 upregulation in colorectal cancer. British Journal of Cancer 2014; 111(2): 365 doi: 10.1038/bjc.2014.253
|
| 23 |
Lan Yu, Lei Zhou, Shiwu Wu, Xiaomeng Gong, Zhenzhong Feng, Li Ma, Bo Zhu, Nan Yao, Danna Wang, Huiming Dong. Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma. World Journal of Surgical Oncology 2014; 12(1) doi: 10.1186/1477-7819-12-118
|
| 24 |
Minsoo Kang, Suhyun Kim, Jesang Ko. Roles of CD133 in microvesicle formation and oncoprotein trafficking in colon cancer. The FASEB Journal 2019; 33(3): 4248 doi: 10.1096/fj.201802018R
|
| 25 |
M. Cheng, L. Yang, R. Yang, X. Yang, J. Deng, B. Yu, D. Huang, S. Zhang, H. Wang, F. Qiu, Y. Zhou, J. Lu. A microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133 expression. Carcinogenesis 2013; 34(10): 2292 doi: 10.1093/carcin/bgt181
|
| 26 |
Mizuho Sato-Dahlman, Yoshiaki Miura, Jing Li Huang, Praveensingh Hajeri, Kari Jacobsen, Julia Davydova, Masato Yamamoto. CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer. Oncotarget 2017; 8(44): 76044 doi: 10.18632/oncotarget.18340
|
| 27 |
Mehran Pashirzad, Thozhukat Sathyapalan, Afsana Sheikh, Prashant Kesharwani, Amirhossein Sahebkar. Cancer stem cells: An overview of the pathophysiological and prognostic roles in colorectal cancer. Process Biochemistry 2022; 115: 19 doi: 10.1016/j.procbio.2022.02.006
|
| 28 |
Shiwu Wu, Lan Yu, Danna Wang, Lei Zhou, Zenong Cheng, Damin Chai, Li Ma, Yisheng Tao. Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-535
|
| 29 |
Jun He, Li Xiong, Qinglong Li, Liangwu Lin, Xiongying Miao, Shichao Yan, Zhangyong Hong, Leping Yang, Yu Wen, Xiyun Deng. 3D modeling of cancer stem cell niche. Oncotarget 2018; 9(1): 1326 doi: 10.18632/oncotarget.19847
|
| 30 |
Cho-Won Kim, Hong Kyu Lee, Min-Woo Nam, Gabsang Lee, Kyung-Chul Choi. The Role of <i>KiSS1</i> Gene on the Tumor Growth and Migration of Prostate Cancer and the Underlying Molecular Mechanisms. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4153272
|
| 31 |
Salima Shebbo, Najat Binothman, Manar Darwaish, Hanan A. Niaz, Rwaa H. Abdulal, Jamilah Borjac, Anwar M. Hashem, Ahmad Bakur Mahmoud. Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1350208
|
| 32 |
Wei Rao, Shuting Zhao, Jianhua Yu, Xiongbin Lu, Debra L. Zynger, Xiaoming He. Enhanced enrichment of prostate cancer stem-like cells with miniaturized 3D culture in liquid core-hydrogel shell microcapsules. Biomaterials 2014; 35(27): 7762 doi: 10.1016/j.biomaterials.2014.06.011
|
| 33 |
Mahin Mohammadi, Michael Bzorek, Jesper Hansen Bonde, Hans J Nielsen, Susanne Holck. The stem cell marker CD133 is highly expressed in sessile serrated adenoma and its borderline variant compared with hyperplastic polyp. Journal of Clinical Pathology 2013; 66(5): 403 doi: 10.1136/jclinpath-2012-201192
|
| 34 |
Wei-Chih Kuan, Daniel Horák, Zdeněk Plichta, Wen-Chien Lee. Immunocapture of CD133-positive cells from human cancer cell lines by using monodisperse magnetic poly(glycidyl methacrylate) microspheres containing amino groups. Materials Science and Engineering: C 2014; 34: 193 doi: 10.1016/j.msec.2013.09.009
|
| 35 |
Alireza Mirzaei, Gholamreza Tavoosidana, Mohammad Hossein Modarressi, Afshin Abdi Rad, Mohammad Sadegh Fazeli, Reza Shirkoohi, Masoumeh Tavakoli-Yaraki, Zahra Madjd. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients. Tumor Biology 2015; 36(6): 4801 doi: 10.1007/s13277-015-3132-9
|
| 36 |
XUEFANG WU, FENG LUO, JINBANG LI, XUEYUN ZHONG, KUNPING LIU. Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway. International Journal of Oncology 2016; 48(4): 1333 doi: 10.3892/ijo.2016.3360
|
| 37 |
Shan-shan Zhang, Zhi-peng Han, Ying-ying Jing, Shuang-fen Tao, Tie-jun Li, Hao Wang, Yang Wang, Rong Li, Yang Yang, Xue Zhao, Xiao-dong Xu, En-da Yu, Yao-cheng Rui, Hou-jia Liu, Li Zhang, Li-xin Wei. CD133+CXCR4+ colon cancer cells exhibit metastatic potential and predict poor prognosis of patients. BMC Medicine 2012; 10(1) doi: 10.1186/1741-7015-10-85
|
| 38 |
Phaik-Leng Cheah, Jing Li, Lai-Meng Looi, Kean-Hooi Teoh, Diana Bee-Lan Ong, Mark J. Arends. DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinoma. PeerJ 2018; 6: e5530 doi: 10.7717/peerj.5530
|